406 related articles for article (PubMed ID: 31332342)
1. Phage-guided modulation of the gut microbiota of mouse models of colorectal cancer augments their responses to chemotherapy.
Zheng DW; Dong X; Pan P; Chen KW; Fan JX; Cheng SX; Zhang XZ
Nat Biomed Eng; 2019 Sep; 3(9):717-728. PubMed ID: 31332342
[TBL] [Abstract][Full Text] [Related]
2. Phages Enter the Fight against Colorectal Cancer.
Kannen V; Parry L; Martin FL
Trends Cancer; 2019 Oct; 5(10):577-579. PubMed ID: 31706504
[TBL] [Abstract][Full Text] [Related]
3.
Wu QL; Fang XT; Wan XX; Ding QY; Zhang YJ; Ji L; Lou YL; Li X
World J Gastroenterol; 2024 Apr; 30(14):2018-2037. PubMed ID: 38681125
[TBL] [Abstract][Full Text] [Related]
4. Aspirin Modulation of the Colorectal Cancer-Associated Microbe Fusobacterium nucleatum.
Brennan CA; Nakatsu G; Gallini Comeau CA; Drew DA; Glickman JN; Schoen RE; Chan AT; Garrett WS
mBio; 2021 Apr; 12(2):. PubMed ID: 33824205
[TBL] [Abstract][Full Text] [Related]
5. Metformin elicits antitumour effect by modulation of the gut microbiota and rescues Fusobacterium nucleatum-induced colorectal tumourigenesis.
Huang X; Hong X; Wang J; Sun T; Yu T; Yu Y; Fang J; Xiong H
EBioMedicine; 2020 Nov; 61():103037. PubMed ID: 33039709
[TBL] [Abstract][Full Text] [Related]
6. Phage-boosted chemotherapy.
Aggarwal N; Hwang IY; Chang MW
Nat Biomed Eng; 2019 Sep; 3(9):680-681. PubMed ID: 31501566
[No Abstract] [Full Text] [Related]
7. Delivery of short chain fatty acid butyrate to overcome Fusobacterium nucleatum-induced chemoresistance.
Chen L; Zhao R; Kang Z; Cao Z; Liu N; Shen J; Wang C; Pan F; Zhou X; Liu Z; Yang Y; Chen Q
J Control Release; 2023 Nov; 363():43-56. PubMed ID: 37734673
[TBL] [Abstract][Full Text] [Related]
8. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
[TBL] [Abstract][Full Text] [Related]
9.
Yin H; Miao Z; Wang L; Su B; Liu C; Jin Y; Wu B; Han H; Yuan X
Aging (Albany NY); 2022 Feb; 14(4):1941-1958. PubMed ID: 35212644
[TBL] [Abstract][Full Text] [Related]
10. Oral microbiota affects the efficacy and prognosis of radiotherapy for colorectal cancer in mouse models.
Dong J; Li Y; Xiao H; Zhang S; Wang B; Wang H; Li Y; Fan S; Cui M
Cell Rep; 2021 Oct; 37(4):109886. PubMed ID: 34706245
[TBL] [Abstract][Full Text] [Related]
11. Orally available dextran-aspirin nanomedicine modulates gut inflammation and microbiota homeostasis for primary colorectal cancer therapy.
Ma S; Yao H; Si X; Huang Z; Wang R; Wan R; Tang Z; Wang G; Song W
J Control Release; 2024 Jun; 370():528-542. PubMed ID: 38705520
[TBL] [Abstract][Full Text] [Related]
12. Predictive values of colon microbiota in the treatment response to colorectal cancer.
Galan-Ros J; Ramos-Arenas V; Conesa-Zamora P
Pharmacogenomics; 2020 Sep; 21(14):1045-1059. PubMed ID: 32896201
[TBL] [Abstract][Full Text] [Related]
13.
Brennan CA; Clay SL; Lavoie SL; Bae S; Lang JK; Fonseca-Pereira D; Rosinski KG; Ou N; Glickman JN; Garrett WS
Gut Microbes; 2021; 13(1):1987780. PubMed ID: 34781821
[TBL] [Abstract][Full Text] [Related]
14. [Gut microbiota: What impact on colorectal carcinogenesis and treatment?].
Bruneau A; Baylatry MT; Joly AC; Sokol H
Bull Cancer; 2018 Jan; 105(1):70-80. PubMed ID: 29217301
[TBL] [Abstract][Full Text] [Related]
15. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
Nosho K; Sukawa Y; Adachi Y; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yamamoto I; Ishigami K; Igarashi H; Maruyama R; Imai K; Yamamoto H; Shinomura Y
World J Gastroenterol; 2016 Jan; 22(2):557-66. PubMed ID: 26811607
[TBL] [Abstract][Full Text] [Related]
16. Bioinorganic hybrid bacteriophage for modulation of intestinal microbiota to remodel tumor-immune microenvironment against colorectal cancer.
Dong X; Pan P; Zheng DW; Bao P; Zeng X; Zhang XZ
Sci Adv; 2020 May; 6(20):eaba1590. PubMed ID: 32440552
[TBL] [Abstract][Full Text] [Related]
17. Gut bacteria identified in colorectal cancer patients promote tumourigenesis via butyrate secretion.
Okumura S; Konishi Y; Narukawa M; Sugiura Y; Yoshimoto S; Arai Y; Sato S; Yoshida Y; Tsuji S; Uemura K; Wakita M; Matsudaira T; Matsumoto T; Kawamoto S; Takahashi A; Itatani Y; Miki H; Takamatsu M; Obama K; Takeuchi K; Suematsu M; Ohtani N; Fukunaga Y; Ueno M; Sakai Y; Nagayama S; Hara E
Nat Commun; 2021 Sep; 12(1):5674. PubMed ID: 34584098
[TBL] [Abstract][Full Text] [Related]
18. The Inhibitory Effect of Gut Microbiota and Its Metabolites on Colorectal Cancer.
Chen C; Li H
J Microbiol Biotechnol; 2020 Nov; 30(11):1607-1613. PubMed ID: 32522960
[TBL] [Abstract][Full Text] [Related]
19. The alterations of microbiota and pathological conditions in the gut of patients with colorectal cancer undergoing chemotherapy.
Yixia Y; Sripetchwandee J; Chattipakorn N; Chattipakorn SC
Anaerobe; 2021 Apr; 68():102361. PubMed ID: 33781900
[TBL] [Abstract][Full Text] [Related]
20. Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy.
Yu T; Guo F; Yu Y; Sun T; Ma D; Han J; Qian Y; Kryczek I; Sun D; Nagarsheth N; Chen Y; Chen H; Hong J; Zou W; Fang JY
Cell; 2017 Jul; 170(3):548-563.e16. PubMed ID: 28753429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
